Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: Fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS)

EuroIntervention

Volumn 7, Issue 6, 2011, Pages 670-679

  Morice, Marie Claude ^a   Feldman, Ted E ^b   Mack, Michael J ^c   Ståhle, Elisabeth ^d   Holmes, David R ^e   Colombo, Antonio ^f   Morel, Marie Angèle ^g   Van Den Brand, Marcel ^g   Serruys, Patrick W ^h   Mohr, Friedrich ⁱ   Carrié, Didier ^j   Fournial, Gerard ^j   James, Stefan ^d   Leadley, Katrin ^k   Dawkins, Keith D ^k   Kappetein, A Pieter ^h  

^a INSTITUT HOSPITALIER JACQUES CARTIER   (France)

^b EVANSTON HOSPITAL   (United States)

^c Heart Hospital Baylor Plano   (United States)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e MAYO CLINIC   (United States)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g CARDIALYSIS   (Netherlands)

^h ERASMUS MEDICAL CENTER   (Netherlands)

ⁱ UNIVERSITY OF LEIPZIG   (Germany)

^j CHU RANGUEIL   (France)

^k BOSTON SCIENTIFIC CORPORATION   (United States)

more..

Author keywords

Angiography; Bypass; Drug eluting stent; Left main disease syntax

Indexed keywords

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY STENT; FEMALE; FOLLOW UP; GRAFT OCCLUSION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; VASCULAR PATENCY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; EUROPE; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REGISTRIES; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VASCULAR PATENCY;

EID: 80155127392     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I6A109     Document Type: Article

References (32)

1. Cho KR, Kim JS, Choi JS, Kim KB. Serial angiographic followup of grafts one year and five years after coronary artery bypass surgery. Eur J Cardiothorac Surg 2006;29:511-6.
2. Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB, Jr., Lorenz TJ, Goyal A, Gibson M, Mack MJ, Gennevois D, Califf RM, Kouchoukos NT. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA 2005;294:2446-54. (Pubitemid 41627922)
3. Yilmaz MB, Guray Y, Altay H, Demirkan B, Caldir V, Guray U, Biyikoglu SF, Sasmaz H, Kisacik HL, Korkmaz S. Fate of internal mammary artery grafted to left anterior descending artery is influenced by native vessel stenosis and viable myocardium. Angiology 2009;60:201-6.
4. Schwann TA, Zacharias A, Riordan CJ, Durham SJ, Shah AS, Habib RH. Sequential radial artery grafts for multivessel coronary artery bypass graft surgery: 10-year survival and angiography results. Ann Thorac Surg 2009;88:31-9.
5. Arima M, Kanoh T, Okazaki S, Iwama Y, Matsuda S, Nakazato Y. Long-term clinical and angiographic follow-up in patients with isolated ostial stenosis of the left coronary artery. Circ J 2009;73:1271-7.
6. Desai ND, Naylor CD, Kiss A, Cohen EA, Feder-Elituv R, Miwa S, Radhakrishnan S, Dubbin J, Schwartz L, Fremes SE. Impact of patient and target-vessel characteristics on arterial and venous bypass graft patency: insight from a randomized trial. Circulation 2007;115:684-91. (Pubitemid 46294758)
7. Park SJ, Kim YH, Lee BK, Lee SW, Lee CW, Hong MK, Kim JJ, Mintz GS, Park SW. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol 2005;45:351-6. (Pubitemid 40186783)
8. Vaquerizo B, Lefevre T, Darremont O, Silvestri M, Louvard Y, Leymarie JL, Garot P, Routledge H, de Marco F, Unterseeh T, Zwahlen M, Morice MC. Unprotected left main stenting in the real world: two-year outcomes of the French left main taxus registry. Circulation 2009;119:2349-56.
9. Mehilli J, Kastrati A, Byrne RA, Bruskina O, Iijima R, Schulz S, Pache J, Seyfarth M, Massberg S, Laugwitz K-L, Dirschinger J, Schomig A. LEFT-MAIN Intracoronary Stenting and Angiographic Results: Drug-Eluting Stents for Unprotected Coronary Left Main Lesions Study Investigators. J Am Coll Cardiol 2009;53:1760-68.
10. Erglis A, Narbute I, Kumsars I, Jegere S, Mintale I, Zakke I, Strazdins U, Saltups A. A randomized comparison of paclitaxeleluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis. J Am Coll Cardiol 2007;50: 491-7. (Pubitemid 47126783)
11. Gao RL, Xu B, Chen JL, Yang YJ, Qiao SB, Li JJ, Qin XW, Yao M, Liu HB, Wu YJ, Yuan JQ, Chen J. Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease: comparison with bare-metal stent implantation. Am Heart J 2008;155:553-61.
12. Carrie D, Eltchaninoff H, Lefevre T, Silvestri M, Levy G, Maupas E, Brunel P, Fajadet J, Le Breton H, Gilard M, Blanchard D, Glatt B. Twelve month clinical and angiographic outcome after stenting of unprotected left main coronary artery stenosis with paclitaxel-eluting stents-results of the multicentre FRIEND registry. EuroIntervention 2009;4:449-56.
13. Valgimigli M, Malagutti P, van Mieghem CAG, Vaina S, Ligthart JM, Sianos G, Serruys PW. Persistence of Neointimal Growth 12 Months After Intervention and Occurrence of Delayed Restenosis in Patients With Left Main Coronary Artery Disease Treated With Drug-Eluting Stents. J Am Coll Cardiol 2006;47: 1491-94.
14. Sheiban I, Sillano D, Biondi-Zoccai G, Chieffo A, Colombo A, Vecchio S, Margheri M, Gunn JP, Raina T, Liistro F, Bolognese L, Lee MS, Tobis J, Moretti C. Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study). J Am Coll Cardiol 2009;54:1131-6.
15. Girasis C, Serruys PW, Onuma Y, Colombo A, Holmes DR, Jr., Feldman TE, Bass EJ, Leadley K, Dawkins KD, Morice MC. 3-Dimensional Bifurcation Angle Analysis in Patients With Left Main Disease: A Substudy of the SYNTAX Trial (SYNergy Between Percutaneous Coronary Intervention With TAXus and Cardiac Surgery). JACC Cardiovasc Interv 2010;3:41-48.
16. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Stahle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-72.
17. Ong AT, Serruys PW, Mohr FW, Morice MC, Kappetein AP, Holmes DR, Jr., Mack MJ, van den Brand M, Morel MA, van Es GA, Kleijne J, Koglin J, Russell ME. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 2006;151:1194-204. (Pubitemid 44172867)
18. Ramcharitar S, Onuma Y, Aben JP, Consten C, Weijers B, Morel MA, Serruys PW. A novel dedicated quantitative coronary analysis methodology for bifurcation lesions. EuroIntervention 2008;3: 553-7.
19. Legrand V, Thomas M, Zelizko M, de Bruyne B, Reifart N, Steigen T, Hildick-Smith D, Albiero R, Darremont O, Stankovic G, Pan M, Lassen J, Louvard Y, Lefevre T. Percutaneous coronary intervention of bifurcation lesions: state-of-the-art. Insights from the second meeting of the European Bifurcation Club. EuroIntervention 2007;3:44-49.
20. Morice M-C, Serruys PW, Kappetein AP, Feldman TE, Stahle E, Colombo A, Mack MJ, Holmes DR, Torracca L, van Es G-A, Leadley K, Dawkins KD, Mohr F. Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial. Circulation 2010;121:2645-53.
21. Kushner FG, Hand M, Smith SC, Jr., King SB, 3rd, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE, Jr., Green LA, Hochman JS, Jacobs AK, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DO. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009;120:2271-306.
22. Valgimigli M, Malagutti P, Rodriguez-Granillo GA, Garcia- Garcia HM, Polad J, Tsuchida K, Regar E, Van der Giessen WJ, de Jaegere P, De Feyter P, Serruys PW. Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: an integrated clinical and angiographic analysis based on the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) registries. J Am Coll Cardiol 2006;47:1530-7.
23. Glineur D, Hanet C, Poncelet A, D'Hoore W, Funken J-C, Rubay J, Kefer J, Astarci P, Lacroix V, Verhelst R, Etienne PY, Noirhomme P, El Khoury G. Comparison of Bilateral Internal Thoracic Artery Revascularization Using In Situ or Y Graft Configurations: A Prospective Randomized Clinical, Functional, and Angiographic Midterm Evaluation. Circulation 2008;118: S216-21.
24. Lingaas PS, Hol PK, Lundblad R, Rein KA, Mathisen L, Smith H-J, Andersen R, Thaulow E, Tønnesen TI, Svennevig JL, Hauge SN, Fredriksen PM, Andersen M, Fosse E. Clinical and Radiologic Outcome of Off-Pump Coronary Surgery at 12 Months Follow-Up: A Prospective Randomized Trial. Ann Thorac Surg 2006;81: 2089-95. (Pubitemid 43775548)
25. Shroyer AL, Grover FL, Hattler B, Collins JF, McDonald GO, Kozora E, Lucke JC, Baltz JH, Novitzky D. On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med 2009;361: 1827-37.
26. Berger A, MacCarthy PA, Siebert U, Carlier S, Wijns W, Heyndrickx G, Bartunek J, Vanermen H, De Bruyne B. Long-Term Patency of Internal Mammary Artery Bypass Grafts: Relationship With Preoperative Severity of the Native Coronary Artery Stenosis. Circulation 2004;110:II36-40. (Pubitemid 39263695)
27. Bech GJ, Droste H, Pijls NH, De Bruyne B, Bonnier JJ, Michels HR, Peels KH, Koolen JJ. Value of fractional flow reserve in making decisions about bypass surgery for equivocal left main coronary artery disease. Heart 2001;86:547-52. (Pubitemid 32999868)
28. Gyenes GT, Ghali WA. Should all patients with asymptomatic but significant (>50%) left main coronary artery stenosis undergo surgical revascularization? Circulation 2008;118:422-5.
29. Hahn JY, Song YB, Lee SY, Choi JH, Choi SH, Kim DK, Lee SH, Gwon HC. Serial intravascular ultrasound analysis of the main and side branches in bifurcation lesions treated with the T-stenting technique. J Am Coll Cardiol 2009;54:110-7.
30. Casella G, Klauss V, Ottani F, Siebert U, Sangiorgio P, Bracchetti D. Impact of intravascular ultrasound-guided stenting on long-term clinical outcome: a meta-analysis of available studies comparing intravascular ultrasound-guided and angiographically guided stenting. Catheter Cardiovasc Interv 2003;59:314-21. (Pubitemid 36792388)
31. Ge L, Airoldi F, Iakovou I, Cosgrave J, Michev I, Sangiorgi GM, Montorfano M, Chieffo A, Carlino M, Corvaja N, Colombo A. Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post-dilation. J Am Coll Cardiol 2005;46:613-20. (Pubitemid 41132686)
32. Lefèvre T, Louvard Y, Morice MC, Dumas P, Loubeyre C, Benslimane A, Premchand RK, Guillard N, Piéchaud JF. Stenting of bifurcation lesions: Classification, treatments, and results. Catheter Cardiovasc Interv. 2000;49:274-83.